UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Boosted by Stonebridge Capital Advisors LLC

Stonebridge Capital Advisors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,634 shares of the healthcare conglomerate's stock after purchasing an additional 1,369 shares during the quarter. UnitedHealth Group comprises approximately 1.3% of Stonebridge Capital Advisors LLC's investment portfolio, making the stock its 23rd biggest holding. Stonebridge Capital Advisors LLC's holdings in UnitedHealth Group were worth $16,508,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Sugarloaf Wealth Management LLC increased its stake in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after acquiring an additional 1,193 shares during the period. Signal Advisors Wealth LLC lifted its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares during the period. Waycross Partners LLC grew its holdings in UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after acquiring an additional 658 shares during the period. Czech National Bank grew its stake in shares of UnitedHealth Group by 6.1% in the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock worth $100,937,000 after purchasing an additional 11,426 shares during the last quarter. Finally, Lmcg Investments LLC lifted its stake in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock valued at $19,210,000 after purchasing an additional 4,022 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.3 %

UnitedHealth Group stock opened at $428.25 on Thursday. UnitedHealth Group Incorporated has a 52 week low of $417.12 and a 52 week high of $630.73. The stock has a market capitalization of $391.73 billion, a P/E ratio of 27.63, a PEG ratio of 1.37 and a beta of 0.61. The stock has a 50-day simple moving average of $506.92 and a 200 day simple moving average of $537.23. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.96%. UnitedHealth Group's payout ratio is presently 35.18%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on UNH shares. Mizuho lifted their target price on UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a report on Tuesday. Finally, StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $604.67.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.